Lets not turn this into a pissing match between sponsors guys..
that being said in the main study on cjc 30% of participants reported the flushing, redness, hypertension etc...
I always get it on cjc so if I inject cjc and do not i too will be suspicious.. but without labs we cant be sure..
I have never had one be cloudy either.. not sure what to say about that my man..
Here is the link to clinical trials by CONJUCHEM.. the creator of all things CJC..
**broken link removed**
In the single-dose study, adverse events were reported in 33 (94%) vs. two (29%) subjects in the active and placebo groups, respectively; all were of mild to moderate severity, and none required medical intervention to resolve. Injection site reactions (irritation, erythema, induration, pain, or itching) occurred transiently (up to several hours) in approximately 70% of subjects receiving CJC-1295 and rarely in subjects receiving placebo. Injection site reactions tended to be more severe and/or prolonged after higher doses, with residual induration lasting up to 5 d. No local reaction exceeded 10 cm in diameter, and all resolved spontaneously. Transient urticarial rashes at the injection site occurred in almost 30% of subjects and were not dose related. Other adverse events reported in actively treated subjects included headache (63%), diarrhea (43%), and systemic vasodilatory reactions (flushing, warmth, and transient hypotension; 30%); all were more common at higher doses (125 or 250 μg/kg). Headache and diarrhea occurred occasionally at various times during the 7 d after dosing. Of these adverse events, only headache occurred in the placebo-treated group (14%). Overall, the adverse events observed at 250 μg/kg were moderate in severity and resolved spontaneously after a few hours, whereas the 125 μg/kg dose of CJC-1295 was considered well tolerated.